Innovalve 3TB Data Leak ( $300M ) Listed by handala Ransomware Group: Ransomware Claim — What’s Alleged & What To Do

Ransomware groups and hacktivist actors continue to exploit corporate transitions, including high-value acquisitions, as opportunities to exfiltrate and publicize internal data. In this environment, listings on leak sites often surface before independent confirmation, leaving organizations and individuals to assess claims carefully. The July 2024 listing of Innovalve by the group handala fits this pattern of claimed large-scale data releases tied to recent business deals.

According to the available record, handala listed a 3TB data leak involving Innovalve, described as a startup acquired for $300 million. The number of people affected remains unknown, and public detail on the precise method and full scope is limited. The claim centers on internal files said to have been taken in a ransomware attack, with the group asserting it is publishing the material free of charge.

Inside the incident

The incident was reported on July 26, 2024, under the headline of a 3TB data leak listed by the handala ransomware group. The group's own summary states that on July 17th it leaked 3TB of Innovalve sensitive data. It references the acquisition of the Innovalve startup by the American company Edwards Lifesciences from Sheba for 300 million dollars and frames the release as a corresponding "gift" of that value. The group further claims it had been monitoring the deal for a long time and is now publishing all data about the startup for free.

Public detail does not confirm the exact date of any intrusion, the technical method used, or independent verification of the 3TB volume. The record states only that internal files were exfiltrated in a ransomware attack and that the material was listed for release. No confirmed count of affected individuals has been provided.

The group behind it: handala

Handala is a known hacktivist collective that has publicly claimed responsibility for data leaks and disruptive operations, frequently targeting entities connected to Israel or Western companies involved in regional business. The group typically operates by posting claims and sample data on leak sites, often tying releases to geopolitical or commercial events rather than pure financial extortion. Its activity is well documented in open reporting as opportunistic and publicity-oriented.

In this case, the listing of Innovalve must be treated as an unverified claim by the group. The facts record only what handala itself stated about monitoring the acquisition and releasing the data; no independent confirmation of the full contents or the group's access is supplied in the available record.

Innovalve 3TB Data Leak ( $300M ) and its sector

Innovalve is identified in the record as a startup that was acquired by Edwards Lifesciences, a major American medical-technology firm, from Sheba for 300 million dollars. Organizations of this type typically operate in the medical-device or cardiovascular-innovation space, developing technologies that later integrate into larger corporate portfolios. Such entities commonly hold research data, intellectual property, employee records, partner contracts, and regulatory documentation.

A breach involving a recently acquired medical-technology startup is consequential because the data may include proprietary designs, clinical or pre-clinical information, and personal details of staff or collaborators. Even when the exact contents remain unconfirmed, the combination of high acquisition value and sensitive sector material raises the potential impact on both the acquiring company and any individuals whose information was stored.

The information in question

The facts name the exposed material as internal files exfiltrated in a ransomware attack, with the group claiming a 3TB volume of Innovalve sensitive data. No further breakdown of file types, databases, or specific categories is provided in the public record. Exact contents are therefore unconfirmed.

Organizations of this kind typically hold research and development files, employee and contractor personal data, financial records related to the acquisition, intellectual-property documents, and correspondence with partners or regulators. Because the listing does not itemize what was actually taken or released, any assessment of exposure must remain provisional until more detail becomes available.

What's at stake

For individuals whose information may have been among the internal files, the practical risks include potential misuse of personal or professional details, targeted phishing that references the acquisition or the company, and longer-term exposure if credentials or contact data were present. For the organization and its acquirer, the stakes involve possible disclosure of proprietary research, disruption of integration efforts, and the need to assess whether regulatory or contractual obligations have been triggered.

Because the number of people affected is unknown and the precise data types beyond "internal files" are undisclosed, the scale of individual harm cannot yet be quantified. The claim of a free public release increases the chance that any authentic material could circulate beyond the initial leak site.

Were you affected?

If you have ever worked with, contracted for, or supplied Innovalve or related entities around the time of the reported acquisition, treat the claim as a prompt for caution rather than confirmed exposure. Practical first steps include:

• Monitor financial and email accounts for unusual activity that references the company or the acquisition.
• Change passwords on any accounts that may have been used in professional correspondence with Innovalve or Edwards Lifesciences, and enable multi-factor authentication where available.
• Be alert to phishing messages that cite the $300 million deal or claim to offer "leaked" files as bait.
• Review any personal or professional documents you previously shared with the startup for sensitivity.

Readers can also run a free exposure scan of their email address to check whether their information has already surfaced in known breach data sets. Public detail on this incident remains limited; further verified information, if it emerges, will clarify the actual scope.

AICompiled with AI assistance from public sources and published under our editorial standards.